Skip to main content
. 2018 Jan-Feb;51(1):26–31. doi: 10.1590/0100-3984.2016.0171

Table 1.

Revised (2009) International Federation of Gynecology and Obstetrics Staging System for Endometrial Cancer.

Stage Finding(s)
I* Tumor confined to the corpus uteri
IA* No invasion or invasion of less than half of the myometrium
IB* Invasion of half or more than half of the myometrium
II* Tumor invading the cervical stroma but not extending beyond the uterus
III* Local and/or regional spread of the tumor
IIIA* Tumor invading the serosa of the corpus uteri and/or adnexa
IIIB* Vaginal and/or parametrial involvement
IIIC* Metastases to pelvic and/or para-aortic lymph nodes
IIIC1* Positive pelvic lymph nodes
IIIC2* Positive para-aortic lymph nodes with or without positive pelvic lymph nodes
IV* Tumor invading the bladder and/or bowel mucosa, with or with-out distant metastases
IVA* Tumor invading the bladder and/or bowel mucosa
IVB* Distant metastases, including intra-abdominal metastases and/ or inguinal lymph nodes
*

G1, G2, or G3.

Endocervical glandular involvement only should now be considered indicative of stage I rather than stage II.

Positive cytology should be reported separately and does not alter the stage.